ABSTRACT. Because it has recently been hypothesized that human milk is antiinflammatory, the effects of aqueous human colostrum on human polymorphonuclear leukocyte (PMN) respiratory burst activity and selected enzymatic activities was examined. Aqueous colostrum was found to spontaneously reduce ferricytochrome C in a concentration-dependent manner, prohibiting use of the standard assay to measure superoxide production. It also caused a significant concentration-dependent prolongation of the lagtime from stimulation of PMN with phorbol myristate acetate to the appearance of hydrogen peroxide. Substitution of an enzymatic peroxide-generating system for PMN did not alter the effect of colostrum. Colostrum also suppressed myeloperoxidase activity and lysozyme activity, but not @-glucuronidase activity in PMN lysates. The PMN is the acute inflammatory cell of the body, and as such, performs two important roles: microbial killing and propagation/modulation of acute inflammation (1). Proper performance of these roles is dependent on an intact capability to generate oxygen metabolites via the respiratory burst (2, 3). Although the presence of large numbers of PMN in a physiologic fluid other than blood is usually taken as evidence of acute inflammation, human colostrum contains approximately 2 x lo6 PMN/ml (4) without evidence of acute inflammation in the breast. The PMN present in colostrum are hypofunctional compared to blood PMN, having decreased oxygen metabolism and bactericidal activity (4) as well as depressed chemotactic responsiveness (5). To examine whether the hypofunction of colostral PMN and the lack of acute inflammation in the newly lactating breast might reflect inherent "antiinflammatory" characteristics of human colostrum, we tested the in vitro effects of colostrum on PMN oxygen metabolism at two levels: oxygen metabolite production by the PMN and oxygen metabolite-mediated cellular injury.
The PMN is the acute inflammatory cell of the body, and as such, performs two important roles: microbial killing and propagation/modulation of acute inflammation (1) . Proper performance of these roles is dependent on an intact capability to generate oxygen metabolites via the respiratory burst (2, 3) . Although the presence of large numbers of PMN in a physiologic fluid other than blood is usually taken as evidence of acute inflammation, human colostrum contains approximately 2 x lo6 PMN/ml (4) without evidence of acute inflammation in the breast. The PMN present in colostrum are hypofunctional compared to blood PMN, having decreased oxygen metabolism and bactericidal activity (4) as well as depressed chemotactic responsiveness (5) . To examine whether the hypofunction of colostral PMN and the lack of acute inflammation in the newly lactating breast might reflect inherent "antiinflammatory" characteristics of human colostrum, we tested the in vitro effects of colostrum on PMN oxygen metabolism at two levels: oxygen metabolite production by the PMN and oxygen metabolite-mediated cellular injury.
METHODS
Colostrum specimens. Samples of human colostrum were collected by breast pump from mothers 1 to 4 days postpartum. The colostrum was kept on ice until separated by centrifugation (4"C, 8 1,000 x g, 30 min). The time from colostrum collection to separation was typically 30-60 min. After centrifugation, the aqueous fraction of the separated colostrum was harvested by puncturing the centrifuge tube above the cell pellet with a needle and pumping the aqueous fraction out at 2-4 ml/min using a peristaltic pump. Aqueous colostrum was stored in aliquots at -70°C until studied; all studies used either fresh aqueous colostrum (never frozen) or aqueous colostrum thawed once. For experiments that used whole, acellular colostrum, fresh colostrum was centrifuged at 300 X g for 10 min at 4" C, the cream layer and aqueous phase decanted, remixed, and then used or frozen in aliquots at -70" C until used.
PMN studies. PMN were purified from heparinized human blood as described (6) . PMN oxygen consumption was measured with a Clark oxygen electrode (7) using PMA, 20 ng/ml final concentration, as the stimulus. In these experiments, PMN were used at 2.5 x lo6 cells/ml. PMA-stimulated neutrophil hydrogen peroxide production was measured by following horseradish peroxidase mediated oxidation of scopoletin by Hz02 (8) . In these experiments, PMN were used at lo6 cells/ml.
For studies examining the effects of aqueous colostrum on PMN enzyme activities, a lysate of purified PMN (approximately 107/ml) was used as the source for the enzymes myeloperoxidase, P-glucuronidase, and lysozyme. Separate aliquots of aqueous colostrum and PMN lysate were assayed for each enzyme. The sum of the enzyme activity in colostrum plus the activity in the PMN lysate activity (referred to as the "predicted7' activity) was then compared to the activity of identical colostrum and PMN lysate aliquots first mixed together and then assayed (referred to as the "observed" activity). Pairs of predicted and observed values were then plotted against one another, and the regression line through the points was compared to a line with a slope of 1 by t test. Myeloperoxidase activity of PMN lysates was measured using 0-dianisidine as the chromagen (9) . Specifically, triplicate 50-pl samples (either PMN lysate + Hz0 colostrum + H20, or colostrum + lysate) were combined with 200 p1 of MPO buffer (made by combining 6 ml of HBSS with Ca++ and Mg++ without phenol red, containing 1 % bovine serum albumin, with 5 ml of 0.1 M phosphate buffer, pH 7.2, with 1 ml of 1.25 mg/ml. 0-dianisidine in water with 1 ml of 0.05% Hz02 in water) and incubated in 96-well microtiter plates for 15 min at room temperature. After 15 min, color formation was read immediately (at 460 nm) on an automated ELISA plate reader. Triplicate determinations were then averaged, and compared as described above. Lysozyme and P-glucuronidase activities were measured by standard methods (10, 11 used to examine interactions between pathogenic enteric bacteria and epithelial cells (13, 14) ] were grown to monolayers in 24-well tissue culture plates using RPMI 1640 media with 10% fetal calf serum, 2 mM glutamine, 50 pg/ml streptomycin, and 50 pg/ ml penicillin added. Monolayers were washed twice with HBSS, and 5 x lo6 purified PMN were added to quadruplicate wells (approximately 10 PMN: 1 HEp-2 cell). PMA (20 ng/ml final concentration), whole, acellular colostrum (10% final concentration), and HBSS were added, and the cell cultures were incubated for 2 h at 37" C. After 2 h the quadruplicate wells were washed twice with HBSS, the cells remaining were solubilized in 6 N NaOH, and the total protein content of each well was determined (1 5) and the quadruplicates were averaged. Cytochrome C reduction. One part aqueous colostrum or diluted aqueous colostrum was mixed with 1 part ferricytochrome C (1.78 mg/ml) and kept at room temperature for 10 min. Ferricytochrome C reduction was then quantitated by measuring the OD549 of each sample and comparing it to a blank that substituted water for the aqueous colostrum. Acellular production of hydrogen peroxide. In some experiments, an acellular H202-generating system was substituted for purified PMN. In these experiments, a stock glucose solution (1 M) was used to bring the final glucose concentration to 10 mM, and glucose oxidase, 0.25 U, was added. At 35" C, pH 5.1, this system produces 250 nmol of H20z/min; under the assay conditions used (room temperature, pH 7), this system produces 65.19 k 5.76 nmol H202/min. Calculation of colostral reducing activity. Cytochrome C-reducing activity of colostrum was calculated by a standard method (16) and is expressed in nmol/ml. H202-depleting activity was calculated by multiplying the lag time (in min) by the final rate of H202 production (in nmol/min), divided by the volume of colostrum added. Electrophoretic concentration of colostrum. Aliquots of aqueous colostrum were diluted 2-to 4-fold with 0.001 M phosphate buffer, pH 8. They were then concentrated using an electrophoretic concentrator (ISCO, Lincoln, NB) with 3.5-kDa dialysis membranes at either end of the concentration cuvette. This device uses an electric field to concentrate charged molecules at the surface of a dialysis membrane with defined mol. wt. exclusion characteristics (17) . The charge of the targeted molecule is controlled by the pH of the dilution buffer used. Dilution buffer of pH 8 was used to dilute the colostrum based on preliminary experiments examining both the electrophoretic mobility and the pH stability of the colostrum activities. Concentration was performed for 2 W hours per cuvette at 4" C.
Data shown are the mean + SEM; unless otherwise noted, statistical significance was determined by paired sample t test whenever natural pairing occurred; otherwise, Student's t test was used.
RESULTS

Effects of aqueous colostrum on PMN oxygen metabolism and enzymes.
Initial experiments performed to examine whether aqueous colostrum had an effect on PMN superoxide production demonstrated that aqueous colostrum reduced ferricytochrome C spontaneously (Fig. 1) . The degree of ferricytochrome C reduction was dependent on the amount of colostrum added; time course experiments showed that ferricytochrome C reduction began immediately on mixture, and was complete by 10 min at room temperature. Spontaneous reduction of cytochrome C was not affected by the presence of superoxide dismutase (75 U/ml). In comparison, the antioxidants; methionine (1 mM), mannitol (50 mM), and dimethylsulfoxide (280 mM) did not spontaneously cause ferricytochrome C reduction. Aqueous colostrum was also found to spontaneously reduce 0.1 % nitroblue tetrazolium (data not shown). The ferricytochrome C reducing capacity of aqueous colostrum was calculated to be 497 + 47 nmol/ml ( n = 17). Boiling (10 min at 100" C) resulted in retention of 96 k I 1 % of this activity ( n = 4).
Because PMN superoxide production could not be assessed in the presence of aqueous colostrum, PMA-stimulated hydrogen peroxide production by PMN was examined. Aqueous colostrum caused a dose-dependent prolongation of the lagtime from PMA addition to scopoletin oxidation (Hz02 production) (Fig. 2, left) .
This increase in the lag time was not due to delay in the onset of the respiratory burst, as aqueous colostrum had no effect on the time of onset of PMA stimulated oxygen consumption (Fig. 2,  right) . The effect of 10% aqueous colostrum on the rate of Hz02 production by PMN could not be evaluated because of the prolonged lagtimes it caused. Lagtime prolongation was still seen in the presence of 2.5% colostrum, and at that concentration, the rate of PMN H202 production was not significantly different than control (1 5 .98 +-2.17 versus 15.08 a 2.39 nmol H202/min/ 2.5 x lo6 PMN, control versus 2.5% colostrum, n = 7).
Aqueous colostrum had no effect on PMN P-glucuronidase activity, assessed by comparing the activity of the enzyme in the absence (Fig. 3, predicted) , and presence (Fig. 3, observed) of aqueous colostrum. In the presence of 50% aqueous colostrum, P-glucuronidase activity was 105.8 -+ 7.0% of control. Aqueous colostrum significantly depressed both PMN myeloperoxidase and lysozyme activities (Fig. 3, middle and bottom) Effects of aqueous colostrum on an acellular H202-producing system. To simplify examination of the effects of aqueous colostrum on PMN H202 production, an enzymatic H202-producing system was substituted for PMN in further experiments. In the presence of excess glucose, glucose oxidase produces H202 at a constant rate, which is dependent on the glucose oxidase concentration. Aqueous colostrum delayed onset of scopoletin oxidation by this Hz02 producing system in a dose-dependent fashion, similar to its effect on PMN produced H202 (Fig. 4) . The H202 depleting activity of colostrum, using this cell-free system, was 918 + 54 nmollml (n = 18). Boiling (10 min at 100" C) resulted in retention of 5 1 k 11 % of activity (n = 6). In an additional experiment, the effects of high concentrations of colostrum on H202 produced by glucose + glucose oxidase were examined (Fig. 5) . In two of three specimens tested, colostrum concentrations of 90% prolonged the lagtime to the appearance of H202 to more than 60 min.
Ten percent aqueous colostrum did not significantly decrease the rate at which H202 was produced by glucose + glucose oxidase (65.19 + 5.76 versus 54.79 + 7.86 nmollmin, control versus 10% colostrum, n = 10 and 9, respectively). Treatment of colostrum with 50 mM aminotriazole (a catalase inhibitor) for 30 min at 4" C decreased H202-depleting activity to 94 + 8% of control (n = 4). In two experiments, treatment of colostrum with 0.05% sodium azide as an inhibitor of catalase (30 min, room temperature) decreased its H202 depleting activity to 92 and 93% of control. Inclusion of catalase into the cell-free H202-generating system did not produce a lag time; rather, it decreased the apparent rate of Hz02 production. In an experiment not shown, substitution of this H202-producing system for exogenously supplied H202 in the myeloperoxidase assay, with continuous monitoring of myeloperoxidase activity, demonstrated that the suppressive effect of colostrum on myeloperoxidase activity was related to its depleting effect on H202, the substrate for myeloperoxidase. In this system, colostrum caused a delay in the onset of myeloperoxidase activity, but did not affect the rate. To examine the relationship between the aqueous colostrum element responsible for femcytochrome C reduction and the element responsible for depleting H202, the following experiment was performed: colostrum, glucose, and glucose oxidase were combined and the oxidation of scopoletin was monitored fluorometrically. Aliquots of this assay mixture were then removed at different times and examined for ferricytochrome C-reducing activity. Aliquots removed immediately after combining aqueous colostrum, glucose, and glucose oxidase produced initial ferricytochrome C reduction followed by ferricytochrome C reoxidation (Fig. 6A) . Delay of aliquot removal until after the onset of scopoletin oxidation (i.e. H202-depleting activity was exhausted) resulted in no ferricytochrome C reducing activity (Fig.  6B) . Substitution of water for glucose oxidase in the H202 assay resulted in prompt reduction of ferricytochrome C by the aqueous colostrum, which could then be reoxidized by addition of glucose oxidase (Fig. 6, control) .
Electrophoretic concentration of colostral activity. Both the cytochrome C-reducing activity and the H202-depleting activity of colostrum could be electrophoretically concentrated: cytochrome C-reducing activity concentrated 4.2 + 0.4-fold (n = 7); H202-depleting activity concentrated 5.3 + 0.6-fold (n = 6); in three experiments, total colostral protein concentrated 6.9 + 2.7-fold.
DISCUSSION
It is generally accepted that breast-feeding benefits the newborn infant, providing superior nutrition as well as cellular and humoral elements that might bolster the neonate's host defenses. It has recently been hypothesized that human milk might also be antiinflammatory, based on the paucity of inflammatory mediators it contains, the presence of multiple antiinflammatory components in it, and the depressed functional characteristics of many of the leukocytes it contains (1 8). Whether this characteristic is real or how it might or might not be beneficial to the infant is currently speculative.
It is known that colostrum, the initial product of lactation, is different from mature milk in its fat composition, protein composition, and the types of leukocytes it contains (19) . PMN are the predominant phagocytic cell type in colostrum, whereas in transitional and mature milk, mononuclear phagocytes predominate. The PMN plays a major role in acute inflammation, and the presence of large numbers of PMN in body tissues or fluids (except bone marrow and blood) is synonymous with acute inflammation. The presence of relatively large numbers of PMN in colostrum typically without signs of acute mammary inflammation is somewhat paradoxical. We hypothesized that the PMN present in colostrum are the result of maternal host defense responses to opening up new potential routes of microbial invasion from the environment (1.e. initiating lactation), and that the presence of such activated, exudate PMN would be potentially injurious to the naive, neonatal intestinal epithelium unless their inflammation-inducing capabilities were suppressed. Because the PMN propagates/modulates acute inflammation via its production of oxygen metabolites and secretory products (1, 20) , we chose to examine the effects of aqueous, acellular colostrum on these aspects of PMN function.
We were unable to examine the effects of colostrum on PMN superoxide production using a standard assay (superoxide dismutase inhibitable ferricytochrome C reduction) because acellular colostrum spontaneously reduced the cytochrome C in a rapid, dose-related manner. Interesting facets of this effect were that the reduction was not mediated by an endogenous superoxide generating system (it was not affected by superoxide dismutase), and the reduction did not appear to be enzymatic (the rate rapidly plateaued before complete reduction of the cytochrome C) (Fig. 6, control) . We therefore examined the effects of colostrum on PMN production of H202, the ultimate product of the respiratory burst (2 1).
Colostrum was found to delay the appearance of PMN-produced H202. The data show that this effect was not mediated by interference with the onset of the PMN respiratory burst per se (colostrum did not cause a lag before the onset of oxygen consumption). Using an enzymatic, acellular system to produce H202, the same effect was seen. In both systems, the major effect of colostrum was to delay the appearance of H202, with little effect on its ultimate rate of appearance (Fig. 2) . Such an effect is not likely to be enzymatic, as enzymatic destruction of Hz02 causes dose-dependent changes in the rate of H202 production in this system. Rather, the colostral component(s) is more likely LAGTIME (MINUTES) .
. . reducing activity. Right (top), spontaneous femcytochrome C reducing an oxidizable moiety that is present in micromolar concentrations in whole colostrum, which when completely oxidized by H202, no longer competes with scopoletin for the Hz02 produced either by stimulated PMN or glucose + glucose oxidase. The question arises whether the colostral component that becomes oxidized as cytochrome C is reduced is the same component that is oxidized by H202. Based on the calculated colostral content of each activity (497 and 918 nmol/ml, respectively) they do not appear to be one and the same. However, as shown in Figure 6 , exhaustion of H202-depleting activity in the glucose-glucose oxidase system is temporally related to loss of the cytochrome Creducing activity.
The observed effects of colostrum on myeloperoxidase activity can possibly be explained by its H202-depleting activity. Hydrogen peroxide is the substrate for this enzyme; depletion of exogenously added H202 would result in less apparent enzyme activity, as was observed in the standard assay. By substitution of a continuous source of Hz02 (glucose + glucose oxidase) for exogenously added H202 and following myeloperoxidase activity continuously, it was seen that the suppressive effect of colostrum resulted from a delay in the onset of myeloperoxidase activity, and not a change in the rate of chromogen production.
To examine whether the antioxidant activities of colostrum might have relevance at the cellular level, we tested the effects of colostrum on PMN mediated HEp-2 cell detachment. HEp-2 cells were used because they are an epithelial cell line commonly used to study enteric microorganism/epithelial cell interactions. Because colostrum would exert its effects at the level of the mucosal surface in the intestine, this cell line was considered more appropriate for examining PMN effects than classically used vascular endothelium. As might be anticipated, PMAstimulated PMN caused significant detachment of HEp-2 cells; 10% whole colostrum significantly ameliorated this PMN-mediated effect, consistent with its antioxidant capabilities. It is tempting to speculate that such a sparing effect might help protect the neonatal intestine from potentially injurious maternal PMN that are present in the colostrum.
These studies do not chemically identify the colostral component(~) that mediate its antioxidant activity. The concentration of the antioxidant activity at the surface of a 3.5-kDa dialysis membrane at pH 8 suggests the component(s) is larger than 3.5 kDa and that it carries a positive charge at pH 8. In a single experiment (data not shown) using pH 5 buffer for electrocentration, the antioxidant activity did not concentrate, suggesting that the component(s) is either uncharged or unstable at that pH. A number of small antioxidant compounds are reported to be present in human colostrum: ascorbate is present in concentrations of 47-104 mg/liter (267-591 nmol/ml) in cellular, whole colostrum (22) ; cystine and taurine are present in acellular, aqueous colostrum at concentrations of 25 k 9 and 41 3 k 71 nmol/ml (23); a-tocopherol is present in cellular, whole colostrum at a concentration of about 23 nmol/ml (24) . Studies examining the possible roles of each of these components in colostral antioxidant activity are currently underway.
These studies are the first to show that human colostrum creates a chemically reducing environment in which PMN-produced H202 is not available as an oxidant or a substrate for other PMN enzymatic systems. They also show that colostrum can protect against PMN-mediated cellular injury. Taken together, they support the concept that colostrum is antiinflammatory.
